Abstract
Square jaw contouring: (a, c) before and (b, d) 2 months after 20 U injection of BOTOX® per side
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Smyth AG. Botulinum toxin treatment of bilateral masseteric hypertrophy. Br J Oral Maxillofac Surg. 1994;32:29–33.
Moore AP, Wood GD. The medical management of masseteric hypertrophy with Botulinum toxin type A. Br J Oral Maxillofac Surg. 1994;32:26–8.
Kim SK, Han JJ, Kim JT. Classification and treatment of prominent mandibular angle. Aesthetic Plast Surg. 2001;25:382–7.
von Lindern JJ, Niederhagen B, Appel T, Bergé S, Reich RH. Type A Botulinum toxin for the treatment of hypertrophy of the masseter and temporal muscles: an alternative treatment. Plast Reconstr Surg. 2001;107(2):327–32.
Xu JA, Yuasa K, Yoshiura K, Kanda S. Quantitative analysis of masticatory muscles using computed tomography. Dentomaxillofac Radiol. 1994;23:154–8.
Won SY, Choi DY, Kwak HH, Kim ST, Kim HJ, Hu KS. Topography of the arteries supplying the masseter muscle: Using dissection and Sihler’s method. Clin Anat. 2012;25(3):308–13.
Bae JH, Choi DY, Lee JG, Seo KK, Tansatit T, Kim HJ. The risorius muscle: anatomic considerations with reference to botulinum neurotoxin injection for masseteric hypertrophy. Dermatol Surg. 2014;40(12):1334–9.
Rho NK, Kim HS, Kim YS, et al. Botulinum toxin Type A for facial wrinkles and benign masseter hypertrophy in Korean patients. Korean J Dermatol. 2010;48:823–31.
Choe SW, Cho WI, Lee CK, et al. Effects of Botulinum toxin type A on contouring of the lower face. Dermatol Surg. 2005;31:502–7; discussion 07–8.
Kim JH, Shin JH, Kim ST, et al. Effects of two different units of Botulinum toxin type a evaluated by computed tomography and electromyographic measurements of human masseter muscle. Plast Reconstr Surg. 2007;119:711–7.
Kordylewski L. Morphology of motor end-plate and its size relation to the muscle fibre size in the amphibian submandibular muscle. Z Mikrosk Anat Forsch. 1979;93:1038–50.
Black JD, Dolly JO. Interaction of 125I-labeled botulinum neurotoxin with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves. J Cell Biol. 1986;103:521–34.
Sloop RR, Escutin RO, Matus JA, et al. Dose-response curve of human extensor digitorum brevis muscle function to intramuscularly injected Botulinum toxin type A. Neurology. 1996;46:1382–6.
Bandholm T, Sonne-Holm S, Thomsen C, et al. Calf muscle volume estimates: implications for Botulinum toxin treatment? Pediatr Neurol. 2007;37:263–9.
Kaji R, Osako Y, Suyama K, Maeda T, Uechi Y, Iwasaki M. Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial. J Neurol. 2010;257:1330–7.
Kim HJ, Yum KW, Lee SS, Heo MS, Seo K. Effects of Botulinum toxin type A on bilateral masseteric hypertrophy evaluated with computed tomographic measurement. Dermatol Surg. 2003;29:484–9.
Yu CC, Chen PK, Chen YR. Botulinum toxin a for lower facial contouring: a prospective study. Aesthetic Plast Surg. 2007;31:445–51; discussion 452–3.
Park MY, Ahn KY, Jung DS. Botulinum toxin type A treatment for contouring of the lower face. Dermatol Surg. 2003;29:477–83; discussion 483.
Kim NH, Chung JH, Park RH, Park JB. The use of Botulinum toxin type A in aesthetic mandibular contouring. Plast Reconstr Surg. 2005;115(3):919–30.
To EW, Ahuja AT, Ho WS, King WW, Wong WK, Pang PC, Hui AC. A prospective study of the effect of Botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. Br J Plast Surg. 2001;54(3):197–200.
Lagueny A, Deliac MM, Julien J, et al. Jaw closing spasm-a form of focal dystonia? An electrophysiological study. J Neurol Neurosurg Psychiatry. 1989;52:652–5.
Schwartz M, Freund B. Treatment of temporomandibular disorders with botulinum toxin. Clin J Pain. 2002;18(6 Suppl):S198–203.
Van Zandijcke M, Marchau MM. Treatment of bruxism with Botulinum toxin injections. J Neurol Neurosurg Psychiatry. 1990;53:530.
Kim KS, Byun YS, Kim YJ, Kim ST. Muscle weakness after repeated injection of Botulinum toxin type A evaluated according to bite force measurement of human masseter muscle. Dermatol Surg. 2009;35:1902–6.
Elluru RG. Physiology of the salivary glands. In: Flint P, Haughey B, Lund V, et al. editors. Cummings otolaryngology, 5th ed. Philadelphia: Mosby Elsevier; 2010. Vol 2. Chapter 84. 1138p.
Wu WT. Botox facial slimming/facial sculpting: the role of botulinum toxin-A in the treatment of hypertrophic masseteric muscle and parotid enlargement to narrow the lower facial width. Facial Plast Surg Clin North Am. 2010;18(1):133–40.
Rafferty KL, Liu ZJ, Ye W, Navarrete AL, Nguyen TT, Salamati A, Herring SW. Botulinum toxin in masticatory muscles: short-and long-term effects on muscle, bone, and craniofacial function in adult rabbits. Bone. 2012;50(3):651–62.
Matic DB, Yazdani A, Wells RG, Lee TY, Gan BS. The effects of masseter muscle paralysis on facial bone growth. J Surg Res. 2007;139:243–52.
Chang CS, Bergeron L, Yu CC, Chen PK, Chen YR. Mandible changes evaluated by computed tomography following Botulinum toxin A injections in square-faced patients. Aesthetic Plast Surg. 2011;35(4):452–5.
Fuster Torres MA, BeriniAytés L, Gay EC. Salivary gland application of botulinum toxin for the treatment of sialorrhea. Med Oral Patol Oral Cir Bucal. 2007;12:E511–7.
Teymoortash A, Sommer F, Mandic R, et al. Intraglandular application of botulinum toxin leads to structural and functional changes in rat acinar cells. Br J Pharmacol. 2007;152:161–7.
Bae GY, Yune YM, Seo K, Hwang SI. Botulinum toxin injection for salivary gland enlargement evaluated using computed tomographic volumetry. Dermatol Surg. 2013;39:1404–7.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media Singapore
About this chapter
Cite this chapter
Seo, K.K. (2017). Facial Contouring with Botulinum Toxin. In: Botulinum Toxin for Asians. Springer, Singapore. https://doi.org/10.1007/978-981-10-0204-5_3
Download citation
DOI: https://doi.org/10.1007/978-981-10-0204-5_3
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-0202-1
Online ISBN: 978-981-10-0204-5
eBook Packages: MedicineMedicine (R0)